Cambridge Investment Research Advisors, Inc. Ark Genomic Revolution ETF (De Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.4 Billion
- Q3 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 109,596 shares of ARKG stock, worth $2.7 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
109,596
Previous 111,810
1.98%
Holding current value
$2.7 Million
Previous $2.63 Million
6.9%
% of portfolio
0.01%
Previous 0.01%
Shares
28 transactions
Others Institutions Holding ARKG
# of Institutions
287Shares Held
24.5MCall Options Held
3.02MPut Options Held
2.65M-
Jpmorgan Chase & CO New York, NY2.96MShares$72.9 Million0.01% of portfolio
-
Bank Of America Corp Charlotte, NC2.9MShares$71.6 Million0.01% of portfolio
-
Main Management ETF Advisors, LLC San Francisco, CA2.43MShares$59.9 Million2.95% of portfolio
-
Goldman Sachs Group Inc New York, NY1.81MShares$44.7 Million0.01% of portfolio
-
Citigroup Inc1.68MShares$41.4 Million0.03% of portfolio